Fa. Balzola et al., IGM ANTIBODY AGAINST MEASLES-VIRUS IN PATIENTS WITH INFLAMMATORY BOWEL-DISEASE - A MARKER OF VIRUS-RELATED DISEASE, European journal of gastroenterology & hepatology, 9(7), 1997, pp. 661-663
Objective: Viral infections of the mesenteric microvascular endotheliu
m have been hypothesized as pathogenetic factors in inflammatory bowel
diseases. The aim of this study was to determine whether immunoglobul
in M (IgM) antibody against measles virus is associated with disease.
Patients and methods: The IgM antibody was detected by indirect antibo
dy test in 36 patients with evidence of Crohn's disease (23 males and
13 females, median age 40 years, range 20-66), 22 patients with ulcera
tive colitis (14 males and 8 females, median age 42 years, range 19-65
), 59 patients with a chronic active hepatitis (35 males and 24 female
s, median age 56 years, range 38-77) and 30 blood donors (20 males and
10 females, median age 45 years, range 29-62). Results: Twenty-eight
of 36 patients (78%) with Crohn's disease and 13 of 22 patients (59%)
with ulcerative colitis tested positive as compared to only 3 of 89 (3
.3%) controls (P less than or equal to 0.001). Conclusion: The detecti
on of IgM anti-measles virus in the majority of patients with Crohn's
disease and in about half of ulcerative colitis patients as compared t
o a very low prevalence in patients with other chronic inflammatory di
sease is consistent with the hypothesis that the measles virus has pat
hogenetic implications in inflammatory bowel diseases.